<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26152">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766283</url>
  </required_header>
  <id_info>
    <org_study_id>18614</org_study_id>
    <nct_id>NCT02766283</nct_id>
  </id_info>
  <brief_title>Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure</brief_title>
  <official_title>Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in
      pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice
      setting.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of pediatric patients with detected hypothyroidism after iodinated contrast exposure in a routine clincial practice setting.</measure>
    <time_frame>Up to one year after exposure</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">843</enrollment>
  <condition>Hypothyroidism</condition>
  <arm_group>
    <arm_group_label>Iodinated contrast agents</arm_group_label>
    <description>children age 0-3 years (inclusive), who underwent a iodine contrast enhanced radiological examination.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>iodinated contrast agents</intervention_name>
    <description>Intravascular application</description>
    <arm_group_label>Iodinated contrast agents</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Members of Maccabi Health Services database (Israel)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - All children age 0-3 years (inclusive) who are identified of having undergone a
        radiological examination with intravascular use of an iodinated contrast agent.(e.g.

        contrast enhanced CT, cardioangiography)

        Exclusion Criteria:

          -  Congenital Hypothyroidism or other forms of preexisting hypothyroidism

          -  Preexisting thyroid hormone replacement therapy less than three months of observation
             before the radiological examination (if greater than three months old)

          -  Less than two weeks follow-up available after the contrast exposure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bayer Study Director</last_name>
    <role>Study Director</role>
    <affiliation>Bayer</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Many Locations</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <link>
    <url>http://www.fda.gov/cder/drug/DrugSafety/DrugIndex.htm</url>
    <description>Click here and search for drug information provided by the FDA.</description>
  </link>
  <link>
    <url>http://www.fda.gov/medwatch/safety.htm</url>
    <description>Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.</description>
  </link>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 28, 2016</lastchanged_date>
  <firstreceived_date>May 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Children</keyword>
  <keyword>Iodinated contrast agents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypothyroidism</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Iodine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
